Impact of Change of Head and Neck Position on Cricothyroid Membrane Localization and Membrane Height in Parturient Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
The cricothyroid membrane acts a route through which the upper airway can be accessed in order to provide oxygen and ventilation to patients. The need to provide oxygen and ventilation to patients is essential particularly under general anesthesia, where patients may lose the ability to breathe for themselves. Access through this membrane to provide oxygen and ventilation is critical in emergency situations where other traditional means to access the airway (e.g through endotracheal ventilation, supraglottic airway devices or face mask ventilation) have failed. It is known that due to the physiological changes of pregnancy, the upper airway of the body undergoes changes that can make accessing the airway through traditional means more difficult. Ultrasound is becoming increasingly popular due to its ability to identify the cricothyroid membrane, to improve success in accessing the airway through the cricothyroid membrane. Studies to date in non pregnant adults have shown that alterations in the head and neck position can alter the position and size of the cricothyroid membrane. No study to date however has looked at how changing the position of the head and neck effects the position and size of the cricothyroid membrane in pregnant patients. It is important to study these changes in the pregnant population, given the physiological changes of pregnancy that make accessing the airway through traditional methods more difficult in non pregnant patients. The investigators hypothesize that in pregnant patients in the third trimester, that changing the head from the neutral to maximally extended neck position will alter the position of the cricothyroid membrane in relation to anatomical skin markings between positions. The investigators also hypothesize that in pregnant patients in the third trimester that changing the head from the neutral to maximally extended neck position will increase the size of the cricothyroid membrane. The investigatorsalso aim to determine at what position in the neck a theoretical standardized incision will allow access to the cricothyroid membrane.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2019
CompletedFirst Posted
Study publicly available on registry
October 24, 2019
CompletedStudy Start
First participant enrolled
November 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2019
CompletedSeptember 11, 2020
September 1, 2020
2 months
October 22, 2019
September 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cricothyroid membrane position change
To measure the distance the center of the cricothyroid membrane changes position on ultrasound between neutral and maximal neck extension in third trimester patients.
30 minutes
Secondary Outcomes (2)
Cricothyroid membrane size change
30 minutes
Distance above sternal notch
30 minutes
Study Arms (1)
Ultrasound
EXPERIMENTALUltrasound measurements of the cricothyroid membrane.
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant patients in third trimester (\>28/40 weeks)
- Ability to understand the rationale of the study assessments and to provide signed consent.
You may not qualify if:
- Neck arthritis
- Cervical stenosis
- Known cervical degenerative disc disease
- Rheumatoid Arthritis
- Any restriction of neck movement
- Upper limb neurology
- Patient refusal
- Non pregnant patients
- Pregnant patients less than 28 weeks pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai Hospital
Toronto, Ontario, M5G1X5, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naveed Siddiqui, MD
MOUNT SINAI HOSPITAL
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2019
First Posted
October 24, 2019
Study Start
November 4, 2019
Primary Completion
December 20, 2019
Study Completion
December 20, 2019
Last Updated
September 11, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share